01
Discover
Declared and suspected AI use across clinical, admin, marketing and operational workflows.
CLINICAL AI RISK CHECK
Could your clinic or group show that its AI use is governed, evidenced and under control?
Private GP, dental and specialist clinics are already using ambient scribes, ChatGPT, Copilot, transcription tools and AI-enabled platforms. This short check gives you an advisory view of whether one AI use case looks lower priority, control-dependent or in need of priority governance review.
This tool provides an advisory governance risk indicator only. It is not legal advice, CQC approval, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off.
Designed for one AI use case at a time
No patient data required
Around 2 minutes
Advisory indicator only
Built for private healthcare providers
Private GP clinicsDental practicesSpecialist clinicsAmbient scribe teams
Why this matters
The risk is not AI use. The risk is having no documented position.
Most organisations do not start with a clean AI programme. They start with informal adoption: an ambient scribe in consultation, ChatGPT for drafting, Copilot for admin, transcription tools in meetings, and AI-enabled platforms introduced by suppliers. The governance risk is having no documented position when a patient, DPO, insurer, MDO, CQC inspector, commissioner or board asks how that AI use is controlled.
Interactive check
Your AI Governance Exposure Signal
Select the option that best reflects one AI use case in your clinic or group, for example an ambient scribe, ChatGPT or Copilot use, AI transcription, imaging AI, patient messaging automation or admin workflow automation.
Boundary
What this quick check cannot show you
A short online check cannot discover shadow AI, inspect vendor contracts, confirm DPIA status, review patient transparency wording or evidence how clinicians are using tools in practice. That is why ELSA AI starts with the Clinical AI Exposure Diagnostic™.
02
Evidence
DPIA readiness, vendor data position, human oversight, patient transparency and clinical safety indicators.
03
Decide
A board-readable RAG exposure map and 30-day priority action plan.
04
Govern
A pathway into policy, register, risk register, staff guidance, patient wording and evidence pack.
Clinical AI Exposure Diagnostic™
Need more than a risk signal?
In four working days from completed intake, the Clinical AI Exposure Diagnostic™ gives your clinic or group a documented view of what AI is in use, what patient data may be involved, what evidence is missing and what should be prioritised next.
Clinical AI Exposure Diagnostic™: £5,500 + VAT for the published Standard Diagnostic scope. Where an ambient scribe, AI transcription or note-generation tool is in use, in trial or planned, the engagement routes to the six-working-day ambient scribe assessment from £8,500 plus VAT.
ELSA AI provides advisory governance support only. Final decisions on legal interpretation, DPIA sign-off, clinical safety documentation, insurer notification, MDO disclosure, regulatory engagement and risk acceptance remain with the client’s accountable officers and advisers.